Tomohiro Higa

CIK: 0002054280

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)12 (92.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (7.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TNYA

Tenaya Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (13 total)

TNYA
Tenaya Therapeutics, Inc.
May 18, 2026
Sale(S)
Direct
1.5K shares at avg. $0.79$1K
TNYA
Tenaya Therapeutics, Inc.
Feb 17, 2026
Sale(S)
Direct
611 shares at avg. $0.64$393.117
TNYA
Tenaya Therapeutics, Inc.
Feb 17, 2026
Sale(S)
Direct
2K shares at avg. $0.64$1K
TNYA
Tenaya Therapeutics, Inc.
Feb 17, 2026
Sale(S)
Direct
836 shares at avg. $0.64$537.882
TNYA
Tenaya Therapeutics, Inc.
Feb 3, 2026
Award(A)
Direct
29.3K shares-
TNYA
Tenaya Therapeutics, Inc.
Nov 17, 2025
Sale(S)
Direct
1.4K shares at avg. $1.33$2K
TNYA
Tenaya Therapeutics, Inc.
Aug 18, 2025
Sale(S)
Direct
1.7K shares at avg. $1.25$2K
TNYA
Tenaya Therapeutics, Inc.
Aug 18, 2025
Sale(S)
Direct
717 shares at avg. $1.25$898.401
TNYA
Tenaya Therapeutics, Inc.
Aug 18, 2025
Sale(S)
Direct
523 shares at avg. $1.25$655.319
TNYA
Tenaya Therapeutics, Inc.
May 16, 2025
Sale(S)
Direct
1.4K shares at avg. $0.44$615.353
TNYA
Tenaya Therapeutics, Inc.
Mar 10, 2025
Sale(S)
Direct
1K shares at avg. $0.54$547.553
TNYA
Tenaya Therapeutics, Inc.
Mar 10, 2025
Sale(S)
Direct
620 shares at avg. $0.54$333.808
TNYA
Tenaya Therapeutics, Inc.
Mar 10, 2025
Sale(S)
Direct
845 shares at avg. $0.54$454.948

		Type	Shares	Price		Ownership
May 18, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	1,485	$0.79	$1,178	Direct
Feb 17, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	611	$0.64	$393	Direct
Feb 17, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	2,022	$0.64	$1,300	Direct
Feb 17, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	836	$0.64	$538	Direct
Feb 3, 2026	TNYA Tenaya Therapeutics, Inc.	Award(A)	29,250	-	$0	Direct
Nov 17, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	1,367	$1.33	$1,818	Direct
Aug 18, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	1,722	$1.25	$2,158	Direct
Aug 18, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	717	$1.25	$898	Direct
Aug 18, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	523	$1.25	$655	Direct
May 16, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	1,390	$0.44	$615	Direct
Mar 10, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	1,017	$0.54	$548	Direct
Mar 10, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	620	$0.54	$334	Direct
Mar 10, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	845	$0.54	$455	Direct

1-13 of 13 transactions

About Higa Tomohiro

Higa Tomohiro (SEC CIK 0002054280) files insider reports with the SEC as SVP, Finance of Tenaya Therapeutics, Inc. (TNYA).

Signal8 holds 8 ownership filings by Higa Tomohiro (1 Form 3, 7 Form 4), filed between Feb 7, 2025 and May 19, 2026. Those filings report 13 transactions, from Mar 10, 2025 to May 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Higa Tomohiro's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Higa Tomohiro

May 18, 2026: Open-market sale of TNYA shares (Form 4, code S).
Feb 17, 2026: Open-market sales of TNYA shares (3 lines, Form 4, code S).
Feb 3, 2026: Grant or award of TNYA shares (Form 4, code A).
Nov 17, 2025: Open-market sale of TNYA shares (Form 4, code S).
Aug 18, 2025: Open-market sales of TNYA shares (3 lines, Form 4, code S).

Other insiders filing for Tenaya Therapeutics, Inc. (TNYA)

Ali Faraz, Chief Executive Officer
Tingley Whittemore, Chief Medical Officer
Hyllengren Eric J, Chief Financial Officer
Williams R Sanders, Director
Walsh Jeffrey T., Director
Stehman-Breen Catherine, Director

How to read Form 4 transaction codes